Genta, Inc (fka GNTAQ)

[t h i n k f i s h]

“You Can’t Start a Fire Without a Spark!!”

As Dr. Casey Culberson Said:
"The BEST melanoma patient is an ACTIVE PARTICIPANT in his or her treatment
(not a PASSIVE RECIPIENT)"

http://melanomamissionary.blogspot.com/

TUESDAY, NOVEMBER 10, 2009
E Petition For BMS's Compassionate Investigational Drug Access.Melanoma..Jim Breitfeller
E Petition For BMS's Compassionate Investigational Drug Access

It is time to rally the Melanoma Patients and take back the Clinical Trials.

Bristol-Meyer Squibb halted the compassionate Drugs stating a drug shortage. There is evidence out there that the shorage was over months ago. They left the Melanoma Patients falling through the cracks of the Health Care System. We need change NOW!!!!!

Please sign the E Petition at Melanoma Missionary

Take Care,

Jimmy B

DELCATH INFO

Call for Patients with Unresectable Liver Metastases Due to Melanoma

Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular Melanoma

Delcath is actively enrolling patients in a Phase III clinical trial testing its proprietary drug delivery system, known as Percutaneous Hepatic Perfusion (“PHP”), with melphalan for the treatment of ocular and cutaneous melanoma metastatic to the liver.

Orphan drug designation, when granted by the FDA’s Office of Orphan Products Development, allows for up to seven years of market exclusivity upon FDA approval, as well as clinical study incentives, study design assistance, waivers of certain FDA user fees, and potential tax credits.

Check out the link, useful info.

PEACE For Jimmy B "The BEST melanoma patient"